University Chicago Hospital CTKI258A2201 — Chicago, Illinois

University Chicago Hospital CTKI258A2201 is a clinical research site located in Chicago, Illinois, United States 60637.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University Chicago Hospital CTKI258A2201 has participated in 1 clinical trials.

Therapeutic areas: Urothelial Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University Chicago Hospital CTKI258A2201?

University Chicago Hospital CTKI258A2201 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University Chicago Hospital CTKI258A2201 conducted?

University Chicago Hospital CTKI258A2201 has 1 clinical trials on record. Their work covers Urothelial Cancer.

Is University Chicago Hospital CTKI258A2201 accredited by Crixeo Health?

University Chicago Hospital CTKI258A2201 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University Chicago Hospital CTKI258A2201?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.